Stay updated on Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2 in the page footer. No study content or results appear affected.
    Difference
    0.1%
    Check dated 2026-02-14T12:46:25.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Site footer/template revision updated from v3.4.0 to v3.4.1; no other content or functionality changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-07T06:47:21.000Z thumbnail image
  4. Check
    32 days ago
    Change Detected
    Summary
    Additions include Show glossary, Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0; Deletions include Last Update Submitted that met QC Criteria, No FEAR Act data, and Revision: v3.3.4. These changes pertain to UI labels and documentation metadata rather than core study content; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-24T03:19:59.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    Maintenance revision update detected: v3.3.4 added and v3.3.3 removed, which does not affect trial content or eligibility. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-17T01:28:35.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Added a Locations section listing North Carolina as the study site; removed the previous North Carolina Locations entry and updated the footer to reflect the change.
    Difference
    0.2%
    Check dated 2025-12-19T19:13:28.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    The page shows a minor revision update from v3.3.1 to v3.3.2, with no changes to the study details or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-28T05:47:58.000Z thumbnail image

Stay in the know with updates to Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Paclitaxel and Pembrolizumab in Refractory Urothelial Cancer Clinical Trial page.